文献速递功能神经外科小儿神经外科与脑积水

半侧巨脑回畸形:功能性大脑半球切除术与解剖性大脑半球切除术治疗耐药性癫痫的系统性比较

Hemimegalencephaly: A Systematic Comparison of Functional and Anatomic Hemispherectomy for Drug-Resistant Epilepsy.
PubMed 文献 · Neurosurgery · 2023-11-17

该系统评价与个体患者数据荟萃分析纳入26项研究共145例半侧巨脑回畸形(HME)伴耐药性癫痫患者,比较功能性大脑半球切除术(FH)与解剖性大脑半球切除术(AH)的癫痫结局。末次随访时FH组77%及AH组81%达Engel I级,多因素分析仅双侧发作期脑电图异常与癫痫复发时间更快显著相关(HR=11.5,P=.002),FH较AH预防1例额外脑积水的需治疗人数为3。

要点

  • FH组77%(n=66)、AH组81%(n=38)末次随访达Engel I级。
  • 双侧发作期脑电图异常与癫痫复发时间更快显著相关(HR=11.5,P=.002)。
  • FH较AH预防1例额外大脑半球切除术后脑积水的需治疗人数为3。

核心结论

  • 大脑半球切除术是HME相关耐药性癫痫的高效治疗方法。
  • 单侧发作期脑电图改变及以FH作为初始手术方式可能因大脑半球切除术后脑积水概率显著更低而带来更好结局。
  • 需要更大的HME登记数据库来进一步明确癫痫结局的预测因素。

研究设计与样本

  • 个体患者数据荟萃分析,检索PubMed、Web of Science和Cumulative Index to Nursing and Allied Health Literature自建库至2023年1月13日,纳入报告>3例HME接受AH或FH的癫痫结局的原始文献。
  • 共从26项研究中提取145例患者数据,其中89例接受FH(22例垂直入路、33例侧方入路),47例接受AH,9例接受未指明类型的大脑半球切除术。
  • FH队列末次随访中位时间44.0个月,AH队列45.0个月。
  • 采用双侧t检验和Fisher精确检验比较术后癫痫结局,采用单因素和多因素Cox回归分析识别Engel I结局的独立预测因素。

主要发现

  • 末次随访时FH组77%(n=66)达Engel I级,AH组81%(n=38)达Engel I级。
  • 多因素分析中仅双侧发作期脑电图异常与癫痫复发时间更快显著相关(风险比=11.5;P=.002)。
  • FH较AH预防1例额外大脑半球切除术后脑积水的需治疗人数为3。
  • 侧方与垂直FH入路之间癫痫复发时间差异无统计学意义(风险比=2.59;P=.101)。

关键数值与推荐

  • FH组Engel I级77%(n=66),AH组Engel I级81%(n=38)。
  • 双侧发作期脑电图异常与癫痫复发时间更快的风险比=11.5(P=.002)。
  • 侧方与垂直FH入路癫痫复发时间比较的风险比=2.59(P=.101),无统计学意义。
  • FH较AH预防1例额外大脑半球切除术后脑积水的需治疗人数为3。

临床怎么用

  • 作者认为单侧发作期脑电图改变及以FH作为初始手术管理可能因大脑半球切除术后脑积水概率显著更低而带来更好结局。
  • 作者指出需要更大的HME登记数据库来进一步明确癫痫结局的预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Hemimegalencephaly (HME) is a rare diffuse malformation of cortical development characterized by unihemispheric hypertrophy, drug-resistant epilepsy (DRE), hemiparesis, and developmental delay. Definitive treatment for HME-related DRE is hemispheric surgery through either anatomic (AH) or functional hemispherectomy (FH). This individual patient data meta-analysis assessed seizure outcomes of AH and FH for HME with pharmacoresistant epilepsy, predictors of Engel I, and efficacy of different FH approaches. METHODS: PubMed, Web of Science, and Cumulative Index to Nursing and Allied Health Literature were searched from inception to Jan 13th, 2023, for primary literature reporting seizure outcomes in >3 patients with HME receiving AH or FH. Demographics, neurophysiology findings, and Engel outcome at the last follow-up were extracted. Postsurgical seizure outcomes were compared through 2-tailed t -test and Fisher exact test. Univariate and multivariate Cox regression analyses were performed to identify independent predictors of Engel I outcome. RESULTS: Data from 145 patients were extracted from 26 studies, of which 89 underwent FH (22 vertical, 33 lateral), 47 underwent AH, and 9 received an unspecified hemispherectomy with a median last follow-up of 44.0 months (FH cohort) and 45.0 months (AH cohort). Cohorts were similar in preoperative characteristics and at the last follow-up; 77% (n = 66) of the FH cohort and 81% (n = 38) and of the AH cohort were Engel I. On multivariate analysis, only the presence of bilateral ictal electroencephalography abnormalities (hazard ratio = 11.5; P = .002) was significantly associated with faster time-to-seizure recurrence. A number-needed-to-treat analysis to prevent 1 additional case of posthemispherectomy hydrocephalus reveals that FH, compared with AH, was 3. There was no statistical significance for any differences in time-to-seizure recurrence between lateral and vertical FH approaches (hazard ratio = 2.59; P = .101). CONCLUSION: We show that hemispheric surgery is a highly effective treatment for HME-related DRE. Unilateral ictal electroencephalography changes and using the FH approach as initial surgical management may result in better outcomes due to significantly lower posthemispherectomy hydrocephalus probability. However, larger HME registries are needed to further delineate the predictors of seizure outcomes.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Goel K, Ghadiyaram A, Krishnakumar A, et al. Hemimegalencephaly: A Systematic Comparison of Functional and Anatomic Hemispherectomy for Drug-Resistant Epilepsy. Neurosurgery. 2023. PMID: 37975663. doi:10.1227/neu.0000000000002759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。